Bio-IT World Contributed Commentary | With data emerging as the undisputed driver for 21st Century medicine, it is becoming clear that we cannot expect to design our next generation data infrastructure on the technologies of the last century—technologies that were never intended to handle today’s extreme data volume and workloads.

Bio-IT World | At MD Anderson, the Therapeutics Discovery team aims to develop new treatment options for MD Anderson patients in a much faster way. Two studies published in Nature Medicine earlier this month support the approach, they say.

Bio-IT World Brief | Helix today announced a new CFO, CMO, and CPO, coupled with the acquisition of Denver-based HumanCode.

Bio-IT World | June featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Deloitte, PerkinElmer, iRODS, and more.

Bio-IT World Brief | DataDirect Networks today announced a set of data platforms for artificial intelligence and deep learning. Engineered for the AI data center, DDN’s A³I solutions are optimized to handle the spectrum of AI activities concurrently from data ingest and preparation to training, validation and inference.

Bio-IT World | Traditional high content screening is labor- and time-intensive, and many groups are working to apply deep learning to image analysis. Genedata worked with AstraZeneca to validate a deep learning workflow tool for biologists that can be “unsupervised”—it works without re-engineering across different assay types and settings.